Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on October 20, 2023. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Notice of Intent to Sole Source

Closed
HT9425-23-NOI-JS01Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715
New
Federal
U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)
Solicitation # W911PT26SC001
The U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) has issued solicitation W911PT26SC001, a Commercial Solutions Opening (CSO) authorized under the National Defense Authorization Act for Fiscal Year 2026 and DFARS Subpart 212.70. This competitive solicitation is open until September 30, 2027, and is designed to acquire innovative commercial products, technologies, and services to modernize the Army's Organic Industrial Base. The scope focuses on integrating manufacturing resources, linking legacy analogue systems with digital systems, and expanding modeling and simulation to enhance the delivery of materiel solutions. The CSO targets both traditional and non-traditional business entities, including small businesses and foreign-owned firms, provided they maintain an active System for Award Management (SAM) profile and a Unique Entity ID. The acquisition process follows a multi-phased approach consisting of a written solution brief, an optional presentation or pitch, and a final Request for Commercial Solution Proposal (CSP). Evaluation is based on responsiveness, technical merit, uniqueness, and price reasonableness. Successful responses may result in fixed-price contracts awarded under FAR Part 12 Commercial Item Procedures. Current Areas of Interest (AoIs) include advanced cannon technology, electrical infrastructure improvements at Building 120, chromium facility conversion, automated manufacturing for minor components, automated cooling tower treatments, advanced CNC vertical turning lathes, and advanced tooling for radial forging. Performance is primarily located at Watervliet Arsenal and Benet Laboratories, with a general period of performance not to exceed 12 months unless otherwise specified.
W6QK Acc Wva

POSTED

about 11 hours ago

DEADLINE

in 11 months
NAICS: 541715
New
Grant
National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)
Solicitation # RFA-DC-28-001
Solicitation RFA-DC-28-001 is a Notice of Funding Opportunity issued by the National Institutes of Health under the Department of Health and Human Services to support the NIDCD National Human Ear Resource Network. The objective is to maintain a collaborative network of laboratories that serve as a national technological resource, providing human inner and middle ear tissues to researchers for basic and clinical studies to advance the treatment of auditory and vestibular disorders. The scope of work includes processing human temporal bones from the National Hearing and Balance Organ Donor Program, uploading images and medical data to EarBase, sharing gene-expression data via the gEAR repository, and providing technical instruction to increase the number of skilled researchers in the field. The NIDCD intends to commit 3.6 million dollars in FY 2028 to fund up to six awards, with a maximum project period of five years. Individual awards are limited to 450,000 dollars in direct costs per year, with an additional 150,000 dollars available for specific subawards. Applications are due on March 05, 2027, and November 01, 2027, with staggered start dates ranging from July 2027 to July 2028. Evaluation is based on the experience of the investigators, the adequacy of the institutional environment, and the protection of human subjects. Applicants must maintain active SAM registration and a Unique Entity Identifier, and they must provide a Data Management and Sharing Plan and a Material Transfer Agreement. Compliance with the Cybersecurity Act of 2015 is required, including the development of an incident response plan and notification of cybersecurity incidents within 48 hours of discovery.
National Institutes Of Health

POSTED

about 19 hours ago

DEADLINE

in about 1 year

General Info

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Frederick, MD, 21702, USA

Set-Aside

NONE

Documents

1

Notice of Intent to Sole Source - Digital Twin (HT9425-23-NOI-JS01)

PDF, Low priorityjustification-and-authorization
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency (dha)
Contacts2 people available
OfficeN/A

Full Description

Show more
Notice of Intent to Sole Source (HT9425-23-NOI-JS01) This is a Notice of Intent (NOI) to Sole Source award on the basis of other than full and open competition in accordance with the Federal Acquisition Regulation (FAR) 6.302-1, as only one responsible source and no other supplies or services will satisfy agency requirements, (a)(2)(iii)(A), Substantial duplication of cost to the Government that is not expected to be recovered through competition, and FAR 6.302-1(a)(2)(iii)(B), Unacceptable delays in fulfilling the agencies requirements. This is not a Request for Quotes or Proposals. No contract award will be made on the basis of the responses to this notice. The purpose of this notice is to allow interested parties to assert and explain their capability to satisfy the requirement described. In support of the Telemedicine & Advanced Technology Research Center (TATRC), a Request for Information (RFI) was posted to System for Award Management (SAM) seeking capabilities statements from all capable and qualified sources. The RFI was posted to SAM on 28 September 2023 with all responses/capability statements due by 5 October 2023 at 2:00PM ET. The U.S. Army Medical Research Acquisition Activity (USAMRAA) located at 808 Schrieder Street, Fort Detrick, MD on behalf of TATRC, in support of the Biotechnology HPC Software Applications Institute (BHSAI), intends to award a sole source cost plus fixed fee contract to the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) for support to conduct all elements of research on developing and implementing implement computational artificial intelligence (AI)-based individualized physiological response models that address Warfighter mental acuity and performance, responses to trauma and disease, and protection against extreme temperature environments. This Research and Development (R&D) requirement is to establish and validate individualized predictive analytics models that can serve as a Digital Twin of a Service member to anticipate undesirable physiological and clinical outcomes and make recommendations with sufficient lead time to mitigate, if not completely avoid, these adverse conditions. This R&D effort to support the BHSAI will research, test, and develop a modernized concept that is applicable to individual Warfighters and will allow for the ability to make real-time actionable predictions at the individual level based on unobtrusively monitored physiological data. The Digital Twin's intuitive concept and appealing technology relies on mathematical models to accurately represent and reliably guide decisions and assess the consequences of a given decision. This approach enables the capability to mathematically capture true individuality and make meaningful and accurate predictions. To successfully establish and validate the Digital Twin concept and technology, the following tasks will be completed: execute research in modeling individualized physiological response to trauma and disease; develop personalized mental acuity assessment, monitoring, and optimization research; develop thermoregulatory response models to extreme temperature exposures; provide data management, software development, and integration support for individualized physiological modeling; and report on data management, software development, and integration support for individualized physiological data modeling. All testing and evaluation of different study protocols necessary to collect experimental data requires subject matter expertise provision. The applicable North American Industry Classification System (NAICS) code for this requirement is 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). The Product Service Code (PSC) is AJ11 - General Science and Technology R&D Services; General Science and Technology; Basic Research. Any sources that believe they are eligible and capable of providing these services must respond in writing. Responses must be supported with clear and convincing evidence articulating the ability to provide the services outlined above. A request for documentation will not be considered an affirmative response. Information received will be considered solely for the purposes of determining whether a competitive procurement is in the best interest of the Government. If no written responses are received by the date listed below, which reflects forty-five (45) days after the publication of this notice, the contract will be awarded without further remarks. This notice is provided solely as information to the marketplace. Responses should appear on company letterhead and includes affirmation of active registration in the System of Award Management (SAM), your qualifications and any other applicable data or information. Additionally, respondents should indicate whether they are a large business, small business, small disadvantaged business, 8(a) concern, woman-owned small business, HUBZone, service disabled veteran-owned small business, or qualify as socially or economically disadvantaged and whether they are U.S. or foreign owned. Your response to this Notice of Intent, including any capabilities statement, shall be electronically submitted to the Contract Specialist, Jennifer Sikes, in either Microsoft Word or Portable Document Format (PDF), via email to jennifer.m.sikes2.civ@health.mil no later than (NLT) 2:00 p.m. ET on 5 December 2023 and reference this Notice ID number in the subject line of your e-mail and on all enclosed documents. All data received in response to this Notice of Intent that is marked or designated as corporate or proprietary will be fully protected from any release outside the Government. Responses to this notice will be used to determine the availability of this type of product and/or service. All responsible sources may respond to this notice and all responses will be considered by the agency.

More opportunities from Department Of Defense → Defense Health Agency (dha)

Same awarding agency

NAICS: 325412
Federal
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program
Solicitation # HT9402-26-Q-9404
The Defense Health Agency, acting for the Department of War, is soliciting quotes under solicitation HT9402-26-Q-9404 to establish Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program agreements. This procurement is mandated by 10 U.S.C. 1074g to create an integrated pharmacy benefits program for the Military Health System, covering Military Treatment Facilities, the TRICARE Mail Order Pharmacy, and the Basic Core Formulary. The Pharmacy and Therapeutics Committee will evaluate pharmaceutical agents based on relative clinical effectiveness and cost effectiveness to determine their placement on the Uniform Formulary. Specifically, the November 2026 review includes twelve newly approved drugs across various classes, including oncological agents, antifungals, and insulins. Interested manufacturers must submit quotes by October 26, 2026, and provide detailed clinical data regarding the advantages and therapeutic placement of their drugs. Key requirements include maintaining active SAM.gov registration, ensuring Trade Agreements Act compliance via FAR 52.225-6, and agreeing to utilize the Department of War Prime Vendor Program for distribution. The agreement also requires opening limited distribution channels to Accred for mail order services. Award decisions are based on the combined evaluation of clinical and cost effectiveness, with the TRICARE retail network utilization accrual beginning upon the Contracting Officer's signature. The contract allows for termination by either party with 120 days written notice.
Pharmaceutical Preparation Manufacturing

POSTED

12 days ago

DEADLINE

in 6 days
View Details
NAICS: 541715
Federal
DHA Enterprise-Wide Commercial Solutions Opening (CSO)
Solicitation # HT003826SC005
The Defense Health Agency (DHA) has established the Enterprise-Wide Commercial Solutions Opening (CSO), solicitation number HT003826SC005, to identify and acquire commercial products, services, and non-developmental items. Active from August 7, 2026, through August 6, 2027, this initiative seeks commercially available capabilities that can be deployed immediately or modified to meet DHA requirements across its Medical Digital Solutions, Medical Services, and Medical Products portfolios. The government will utilize a variety of award vehicles, including firm-fixed-price FAR-based contracts and Other Transaction (OT) agreements for research, prototyping, and experimental purposes under authorities such as 10 U.S.C. 3458, 3201, 4021, 4022, and 4023. The procurement process is driven by the issuance of specific Areas of Interest (AoI), which define problem statements, objectives, and submission criteria. Submissions undergo a streamlined, multi-phase evaluation process: Phase I involves a pitch or white paper evaluated on a Go/No-Go basis for strategic alignment and feasibility; Phase II may include an optional oral presentation or demonstration to assess technical viability; and Phase III requires a full commercial proposal evaluated on technical merit, cost reasonableness, and past performance. This CSO is administered by the DHACA Defense Healthcare Management Systems Contracting Division and is designed to prioritize cost-effective, commercially viable solutions to enhance healthcare readiness and patient safety.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

20 days ago

DEADLINE

N/A
View Details
NAICS: 561910
Federal
DHA - Offsite Sterile Processing Support Services
Solicitation # HT9427-27-RFI-0001
The Defense Health Agency (DHA) is issuing a Request for Information (RFI) to identify qualified contractors capable of providing offsite Sterile Processing (SP) support for various Military Treatment Facilities (MTFs) across eight DHA networks. This initiative is part of a Business Case Analysis to improve service resilience and workload stability, ensuring that surgical capabilities are not halted by onsite equipment failures. The scope of work involves the transportation of surgical instruments between MTFs and contractor-owned offsite facilities, where the contractor will provide the necessary personnel, equipment, and facilities to perform decontamination, assembly, sterilization, inventory verification, and quality control. The equipment to be processed includes specialized items such as minimally invasive surgical cases, Da Vinci accessories, and power equipment, with an estimated volume of approximately 2,000 trays monthly per participating MTF. This RFI is strictly for market research and planning purposes and does not constitute a formal solicitation or an obligation to award a contract. The DHA is seeking capability statements from healthcare companies and hospitals that detail their experience with similar projects over the last five years and their proposed implementation strategy. Responses must be submitted in PDF format to the designated Contract Specialist by 11:00 AM EDT on October 30, 2026, and are limited to 10 pages using a 12-point font. The government has not yet determined if a small business set-aside is appropriate and will use the information gathered from these responses to make that decision.
Packaging and Labeling Services

POSTED

21 days ago

DEADLINE

in 10 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS